Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
SOTAC Stock Analysis
Views
Red Flags
Positive
Stock is reasonably valued and PE TTM is at a discount to industry median
Negative
Weak price momentum
Company's earnings are of low quality
Low dividend yield
Neutral
Not enough talking point with neutral stance
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.042121.
Snapshot
See detailed analysis
SOTAC Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
SOTAC Bulk, Block & Insider Trades
SOTAC Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No capital change events found
Company Profile
Sotac Pharmaceuticals Limited is an India-based pharmaceutical company. The Companys services include contract manufacturing, loan license, formulation and development (F & D) and research and development (R & D). It specializes in manufacturing a range of pharmaceutical products having a therapeuti... Read More
Key personnel
Mr. Sharadkumar Dashrathbhai PatelD
Managing Director, Executive Chairman
Mr. Brijeshkumar Ranchhodbhai Patel
Chief Financial Officer
Mr. Pankaj Prabhakar Mahabaleshwarkar
Chief Operating Officer
Ms. Niyati Dipesh Parikh
Chief Compliance Officer, Company Secretary
Mr. Dineshkumar Babulal GelotD
Whole Time Director
Mr. Chetankumar Bachubhai PatelD
Executive Director
Mr. Vishalkumar Devrajbhai PatelD
Executive Director
Mr. Bhavinkumar Prafulbhai JoshiD
Additional Independent Non-Executive Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently Asked Questions about SOTAC
What is the current share price of Sotac Pharmaceuticals Ltd.?
The current share price of Sotac Pharmaceuticals Ltd. is ₹ 124.20 as of 10 Feb 2026.
What is the PE ratio of Sotac Pharmaceuticals Ltd.?
The Price-to-Earnings (PE) ratio of Sotac Pharmaceuticals Ltd. is 17.10 as of the latest financial data.
What is the ROE and ROCE of Sotac Pharmaceuticals Ltd.?
Sotac Pharmaceuticals Ltd. has a Return on Equity (ROE) of 16.30% and a Return on Capital Employed (ROCE) of 11.12% as per the latest financial reports.
What is the market cap of Sotac Pharmaceuticals Ltd.?
The market capitalization of Sotac Pharmaceuticals Ltd. stands at ₹ 137.24 Cr.
What is the dividend yield of Sotac Pharmaceuticals Ltd.?
The dividend yield of Sotac Pharmaceuticals Ltd. is 0.00% based on the current market price.
What is the RSI of Sotac Pharmaceuticals Ltd.?
The Relative Strength Index (RSI) of Sotac Pharmaceuticals Ltd. is 54.40.
What is the FII and DII holding in Sotac Pharmaceuticals Ltd.?
Foreign Institutional Investors (FII) hold 16.14% and Domestic Institutional Investors (DII) hold 0.00% of Sotac Pharmaceuticals Ltd. shares.
What sector does Sotac Pharmaceuticals Ltd. belong to?
Sotac Pharmaceuticals Ltd. operates in the Healthcare sector.
What is the beta of Sotac Pharmaceuticals Ltd. stock?
The beta of Sotac Pharmaceuticals Ltd. stock is 0.84, indicating its volatility relative to the broader market.
